ContinuumRx

ContinuumRx provides home and alternate site-based infusion therapies through a joint venture business model with hospital systems. Founded in 2010 after Principle Pharmacy Group sold its management division, the company focuses exclusively on the home infusion market to provide a seamless transition for patients from hospital to home. The company was originally led by Chairman and CEO Chuck Jett and is now led by CEO Keith P. Hartman. Hartman is an experienced pharmacy entrepreneur, having founded and grown retail, compounding, and specialty pharmacies.

The firm partners with health systems to improve post-acute care coordination, reduce hospital readmissions, and lower overall healthcare costs. This model allows hospitals to offer home infusion services without the operational risks of managing it themselves. ContinuumRx's services include a range of infusion therapies such as antibiotics, enteral and parenteral nutrition, immunoglobulins, heart failure therapies, and other specialty biologic medications. Care is available 24/7, with pharmacists and nurses on-call to support patient needs. The company's clients are health systems and hospitals in the Southern U.S., including locations in Alabama, Tennessee, and Virginia. Revenue is generated through these partnerships, which provide a new revenue source for the hospitals and are supported by the company's proprietary reporting platform that tracks therapy compliance and outcomes for payers and physicians.

Through its subsidiary, Continuum Health, the company also operates full-service infusion clinics that offer a private and comfortable setting for patients, differing from typical hospital environments. In 2015, ContinuumRx secured $13.5 million in a financing round led by NewSpring Capital to fund expansion into new markets. Keywords: home infusion, specialty pharmacy, healthcare partnerships, post-acute care, infusion therapy, care coordination, hospital joint ventures, parenteral nutrition, biologic therapies, chronic condition management